Skip to main content

Table 3 Immunotherapy failure when used as first, second, and third therapies

From: The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt

 

1st Drug

N = 41

(F/T)

2nd Drug

N = 15

(F/T)

3rd Drug

N = 6

(F/T)

Azathioprine (n)

10/22

4/8

2/2

Rituximab(n)

3/7

1/2

1/3

Cyclophosphamide(n)

4/8

1/2

1/1

Mitoxantrone (n)

1/2

3/3

0

Mycophenolate (n)

1/2

0

0

  1. F Failed, T Total